Page last updated: 2024-10-17

n(1)-methylnicotinamide and Leukemia, Myeloid, Acute

n(1)-methylnicotinamide has been researched along with Leukemia, Myeloid, Acute in 2 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamulevicius, P1
Streffer, C1
Johnson, GS1
Lucas, DL1

Other Studies

2 other studies available for n(1)-methylnicotinamide and Leukemia, Myeloid, Acute

ArticleYear
N-methylnicotinamide as a possible prognostic indicator of recovery from leukaemia in patients treated with total-body irradiation and bone marrow transplants.
    Strahlentherapie, 1984, Volume: 160, Issue:4

    Topics: Adult; Bone Marrow Transplantation; Female; Humans; Leukemia, Myeloid, Acute; Male; Niacinamide; Pro

1984
Formation of the N'-methylnicotinamide adenine dinucleotide derivative of NAD in intact rat pituitary tumor GH3 and human promyelocytic leukemia HL-60 cells.
    Archives of biochemistry and biophysics, 1986, Aug-15, Volume: 249, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cell Line; Guanosine Triphosphate; Humans; Leukemia, Myeloid, Acute

1986